Post-approval studies (Phase 4)Study completedNCT05073133
What this trial is testing
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA)
Who this might be right for
Muscular Atrophy, Spinal
Novartis Pharmaceuticals 16